25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
about
Brain Vascular Imaging TechniquesHistology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.Polymeric 1 H MRI Probes for Visualizing Tumor In Vivo.When should we use contrast material in cardiac MRI?Clinical application value of 3.0T MR diffusion tensor imaging in grade diagnosis of gliomas.Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.A Novel Nano-approach for Targeted Inner Ear Imaging.A scale to measure MRI contrast agent sensitivity.Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits.Ultrasound-guided percutaneous microwave ablation for benign breast lesions: evaluated by contrast-enhanced ultrasound combined with magnetic resonance imaging.Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents.Glymphatic MRI in idiopathic normal pressure hydrocephalus.Challenges and opportunities in developing targeted molecular imaging to determine inner ear defects of sensorineural hearing loss.Magnetic resonance imaging provides evidence of glymphatic drainage from human brain to cervical lymph nodes.Vascular CT and MRI: a practical guide to imaging protocols.Temporal lobe epilepsy lateralization using retrospective cerebral blood volume MRI.
P2860
Q30363574-8D56FE7B-2DF2-4E47-B39E-94EB54ED5E2CQ36316226-30DE92B7-05F9-4CB9-9FE6-19D4CF48785BQ38790916-1E567E4F-FCF5-4AC6-9145-17FFAA8032E1Q39179797-84BB5611-871B-4B4D-B8D4-61433C97336CQ39226290-7F138EB2-F86D-41DA-AF0E-D4E9D05E8A60Q39290073-31974A35-3CCC-45CC-B98D-62D5CA102E68Q41145194-F9EE2B2A-902C-463D-8097-B5CCA29C1474Q42324167-E980ED70-4E56-42F5-81DE-0A45865E01B7Q43114765-34B28AC9-7D7A-4348-9F8B-0CBCB34B9DD1Q43496696-3FE98283-CD6B-435E-A4A9-797CD790C17DQ46071655-6C67276C-329C-4CB0-A8FC-334E7B14C66AQ47154211-27A3A2BD-56E9-440B-8D5C-ABCA0154DF00Q47409412-A95B34EE-2165-4640-A3E7-B6FBA67EA31DQ47622669-7EA5DDDA-1706-4F7E-B819-DF4AC3E0CEDAQ50091564-715E3D29-4388-4209-AA3B-BF231DE923B2Q55196138-BC17CDF7-56AC-4DB0-BDD5-F38AB6D3C82FQ55214852-5A1FE833-C0B1-4B34-B640-8A660AAD58A9Q55560593-57694188-FE44-458C-9C9C-2B8FF0DD68F3
P2860
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@ast
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@en
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@nl
type
label
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@ast
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@en
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@nl
prefLabel
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@ast
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@en
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@nl
P2093
P2860
P50
P1433
P1476
25 Years of Contrast-Enhanced ...... lenges and Future Perspectives
@en
P2093
Filipe Caseiro Alves
Hans H Schild
Hubertus Pietsch
Jan Endrikat
Jeffrey C Weinreb
Kohki Yoshikawa
Konstantin Nikolaou
Kun-Cheng Li
Thomas Frenzel
P2860
P2888
P356
10.1007/S12325-015-0275-4
P407
P577
2016-01-25T00:00:00Z
P5875
P6179
1000993435